A US private equity firm is set to take control of the systems housing NHS patient records following a £300 million deal. The agreement involves the company responsible for the software currently used by the majority of general practitioners across England.
The transaction has prompted calls from doctors and members of parliament for increased scrutiny regarding the management of sensitive health data. Critics have expressed concern over the transfer of control to a private equity entity, suggesting that the arrangement warrants further investigation into the implications for patient privacy and the oversight of national health infrastructure.
In-depth summary · AI, neutral